Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by Western Pacific Wealth Management LP

UNH CUSIP 91324P102 Manager CIK 0001907320

Reported 901 shares, up 106 (13.3%) from the prior quarter.

Reported value 15.3%; share count 13.3% vs. the prior quarter.

Added
% of reported 13F value 0.33% This manager · Q2 2023
Shares 901 Quarter-end amount reported
Reported value $433,057 Fair value at quarter end
Consecutive quarters held 7 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 262000
2022-03-31 266000
2022-06-30 371000
2022-09-30 348000
2022-12-31 443230
2023-03-31 375709
2023-06-30 433057
2023-09-30 433603
2023-12-31 475439
2024-03-31 572440
2024-06-30 463545
2024-09-30 516452
2024-12-31 456365
2025-03-31 157125
2025-06-30 104822
2025-09-30 137084
2025-12-31 131054
2026-03-31 107424
2026-06-30 144224
2026-09-30 124807

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by Western Pacific Wealth Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 340 -7 (-2.0%) 0.11% $124,807 2026-10-16
Q2 2026 Reduced 347 -50 (-12.6%) 0.13% $144,224 2026-08-07
Q1 2026 Unchanged 397 0 (0.0%) 0.11% $107,424 2026-04-17
Q4 2025 Unchanged 397 0 (0.0%) 0.13% $131,054 2026-02-04
Q3 2025 Added 397 +61 (18.2%) 0.13% $137,084 2025-10-21
Q2 2025 Added 336 +36 (12.0%) 0.1% $104,822 2025-07-10
Q1 2025 Reduced 300 -602 (-66.7%) 0.14% $157,125 2025-04-17
Q4 2024 Added 902 +19 (2.2%) 0.37% $456,365 2025-01-24
Q3 2024 Reduced 883 -27 (-3.0%) 0.34% $516,452 2024-10-31
Q2 2024 Reduced 910 -247 (-21.3%) 0.35% $463,545 2024-08-14
Q1 2024 Added 1,157 +254 (28.1%) 0.42% $572,440 2024-05-15
Q4 2023 Added 903 +43 (5.0%) 0.35% $475,439 2024-02-09
Q3 2023 Reduced 860 -41 (-4.6%) 0.36% $433,603 2023-10-26
Q2 2023 Added 901 +106 (13.3%) 0.33% $433,057 2023-08-08
Q1 2023 Reduced 795 -41 (-4.9%) 0.29% $375,709 2023-05-11
Q4 2022 Added 836 +146 (21.2%) 0.37% $443,230 2023-02-03
Q3 2022 Reduced 690 -33 (-4.6%) 0.35% $348,000 2022-10-27
Q2 2022 Added 723 +201 (38.5%) 0.36% $371,000 2022-08-01
Q1 2022 Reduced 522 -1 (-0.2%) 0.19% $266,000 2022-04-21
Q4 2021 New 523 +523 (0.0%) 0.17% $262,000 2022-02-14

Who else reported the position

3260 managers reported UNITEDHEALTH GROUP INC for Q2 2023.

Managers reporting UNITEDHEALTH GROUP INC in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 83,897,141 -453,487 0.96% $40,324,321,851 41 qtrs
BlackRock Inc Reduced 74,159,576 -768,963 0.98% $35,644,058,366 41 qtrs
STATE STREET CORPORATION Added 46,313,751 +764,872 1.17% $22,260,241,281 41 qtrs
FMR LLC Reduced 44,941,437 -573,654 1.81% $21,600,652,314 41 qtrs
Capital World Investors Reduced 29,163,746 -221,802 2.7% $14,017,077,221 41 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 27,941,472 -3,650,418 1.87% $13,429,790,000 41 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 24,692,708 +613,568 2.25% $11,868,303,173 41 qtrs
JPMorgan Chase & Co Added 22,408,471 +2,544,077 1.17% $10,770,407,832 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 17,546,024 +444,629 0.99% $8,410,038,427 41 qtrs
MORGAN STANLEY Added 16,162,707 +1,229,326 0.77% $7,768,444,410 41 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 08, 2023
Filing type
13F-HR
Position type
Stock

Voting authority reported

Sole
901
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.